Oligonucleotide inhibition of the interaction of HIV-1 Tat protein with the trans-activation responsive region (TAR) of HIV RNA

被引:37
作者
Mestre, B
Arzumanov, A
Singh, M
Boulmé, F
Litvak, S
Gait, MJ
机构
[1] MRC, Mol Biol Lab, Cambridge CB2 2QH, England
[2] Univ Bordeaux 2, CNRS, F-33077 Bordeaux, France
来源
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION | 1999年 / 1445卷 / 01期
关键词
HIV-1; Tat protein; TAR RNA; oligonucleotide;
D O I
10.1016/S0167-4781(99)00019-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The interaction of HIV-1 Tat protein with its recognition sequence, the trans-activation responsive region TAR is a potential target for drug discovery against HIV infection. We show by use of an in vitro competition filter binding interference assay that synthetic oligodeoxyribonucleotides complementary to the HIV-1 TAR RNA apical stem-loop and bulge region inhibit the binding of Tat protein or a Tat peptide (residues 37-72) better than two small molecules that have been shown to bind TAR RNA, Hoechst 33258 and neomycin B. The inhibition is not sensitive to length between 13 and 16 residues or precise positioning but shorter oligonucleotides are less effective. Enhanced inhibition was obtained for 16-mer 2'-O-methyl oligoribonucleotide but not for C5-propyne pyrimidine-substituted oligonucleotides, Control non-antisense oligonucleotides were occasionally also effective in filter binding interference but only the complementary antisense 2'-O-methyl oligoribonucleotide was effective in gel mobility shift assays in direct TAR binding or in interference with Tat peptide binding to the TAR stem-loop. This is the first demonstration of effective inhibition of the Tat-TAR interaction by nuclease-stabilized oligonucleotide analogues. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:86 / 98
页数:13
相关论文
共 50 条
  • [21] Inhibition of HIV-1 replication by anti-trans-activation responsive polyamide nucleotide analog
    Kaushik, N
    Basu, A
    Pandey, VN
    ANTIVIRAL RESEARCH, 2002, 56 (01) : 13 - 27
  • [22] A review of HIV-1 Tat protein biological effects
    Pugliese, A
    Vidotto, V
    Beltramo, T
    Petrini, S
    Torre, D
    CELL BIOCHEMISTRY AND FUNCTION, 2005, 23 (04) : 223 - 227
  • [23] An Evolved RNA Recognition Motif That Suppresses HIV-1 Tat/TAR-Dependent Transcription
    Crawford, David W.
    Blakeley, Brett D.
    Chen, Po-Han
    Sherpa, Chringma
    Le Grice, Stuart F. J.
    Laird-Offringa, Ite A.
    McNaughton, Brian R.
    ACS CHEMICAL BIOLOGY, 2016, 11 (08) : 2206 - 2215
  • [24] Effect of different arginine methylations on the thermodynamics of Tat peptide binding to HIV-1 TAR RNA
    Kumar, Santosh
    Maiti, Souvik
    BIOCHIMIE, 2013, 95 (07) : 1422 - 1431
  • [25] Kinetic Studies on the Interaction of HIV-1 Gag Protein with the HIV-1 RNA Packaging Signal
    Rink, Constance
    Kroupa, Tomas
    Datta, Siddhartha A. K.
    Rein, Alan
    VIRUSES-BASEL, 2024, 16 (10):
  • [26] Influence of generation 2-5 of PAMAM dendrimer on the inhibition of Tat peptide/TAR RNA binding in HIV-1 transcription
    Wang, Wei
    Guo, Zhenpeng
    Chen, Yi
    Liu, Tao
    Jiang, Long
    CHEMICAL BIOLOGY & DRUG DESIGN, 2006, 68 (06) : 314 - 318
  • [27] STRUCTURAL STUDIES OF HIV-1 TAT PROTEIN
    BAYER, P
    KRAFT, M
    EJCHART, A
    WESTENDORP, M
    FRANK, R
    ROSCH, P
    JOURNAL OF MOLECULAR BIOLOGY, 1995, 247 (04) : 529 - 535
  • [28] The HIV-1 Tat Protein: Mechanism of Action and Target for HIV-1 Cure Strategies
    Rice, Andrew P.
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (28) : 4098 - 4102
  • [29] Inhibition of CXCR4-dependent HIV-1 infection by extracellular HIV-1 Tat
    Ghezzi, S
    Noonan, DM
    Aluigi, MG
    Vallanti, G
    Cota, M
    Benelli, R
    Morini, M
    Reeves, JD
    Vicenzi, E
    Poli, G
    Albini, A
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 270 (03) : 992 - 996
  • [30] Neamine dimers targeting the HIV-1 TAR RNA
    Riguet, E
    Désiré, J
    Boden, O
    Ludwig, V
    Göbel, M
    Bailly, C
    Décout, JL
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (21) : 4651 - 4655